Trial intelligence / Profile preview

IVIg versus intravenous methylprednisolone in CIDP

2005-001136-76Phase 3Completed

Sponsor
Kedrion Biopharma
Start
Sep 2007
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in chronic inflammatory demyelinating polyneuropathy (CIDP) comparing IVIg with IVMP (2 arms). Started Sep 2007; status: completed.

02

Drugs

immune globulinmethylprednisolone
03

Conditions

chronic inflammatory demyelinating polyneuropathy (CIDP)

Beyond the preview

Go deeper on 2005-001136-76.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-001136-76.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call